sixty breast cancer patients with hormone-resistant metastatic disease who had progressed after chemotherapy with low-dose cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) or with l-phenylalanine mustard underwent treatment with a low-dose adriamycin regimen , i.e. , 20 mg/m2 , intravenously on days 1 and 8 every 28 days .
C0016360
5-fluorouracil
C0950521
cmf